A 62-year-old man with Parkinson disease (PD) on levodopa monotherapy for 5 years presents with motor fluctuations and "on-off" episodes. He experiences predictable end-of-dose deterioration lasting 30–45 minutes before each dose. Examination confirms bradykinesia, rigidity, and postural instability during "off" periods. What is the most appropriate next step in management?